Class Notes (839,006)
Canada (511,179)
Biology (1,140)
BIOL 1010 (90)
Lecture 7

Lecture 7.doc

10 Pages
155 Views
Unlock Document

Department
Biology
Course
BIOL 1010
Professor
James Cheetham
Semester
Fall

Description
Lecture 7: Biotechnology and the Pharmaceutical Industry-Wednesday, October 27, 2010 - look at American TV channel and count the number of drug company ads - marketing of pharmaceuticals - At least a third, especially during Superbowl - In terms of sales, only company that tops out in terms of total gross sale revenue is Japan tobacco company - Then Johnson and Johnson, Merca, Visor (pharmaceuticals) - Changed by biotechnology since we discovered how to use recombinant proteins - Genentech was bought out by a pharmaceutical company - Lots of money to be made in this field - large-scale production of drugs came after discovery of antibiotics - usually drugs deal with small molecules (small number of atoms- Aspirin) - Big companies like small molecules- easy to make, can study how body metabolizes easier - Small companies like big molecules like proteins - Therapeutic hormones- Humulin made in 1982 o If desperate, people would have to extract insulin from human cadavers o Biggest biotech therapeutics on the market - First time in NA, person tested positive for Human Growth Hormone- difficult to test for this unless person tests for several standard deviations above normal o 2010- British apprehended rugbee player o Unintended consequence of developing therapeutic- for short or fragile elderly (reduces chance of breaking bones) o Whole Hollywood subculture about HGH, led by Sylvester Stallone- saying people should take it to feel younger o Interesting spin-off of something designed for therapeutic use - Pharmaceutical: small-molecule drugs (Aspirin, prozac) - Biopharmaceutical: proteins, drugs produced by microscopic organisms (bacteria, yeast), or animal cells in culture, or transgenic animals o HGH, insulin- act like natural compound in body using recombinant DNA technology o Usually identical to natural compount - Whole field of antibody production- blood test for drug (diagnostics) - Bacteria- zone of inhibition where antibiotics are put o Still gets done in clinical labs o If you think you have some infection, nurse takes swab from throat, plates bacteria on dish with different antibiotics- determine which antibiotic would help infection o *Pharmagenomics- tailoring medication to your genome, like tailoring medication to particular infection you have - Ancient Egyptians o Idea of using fungus as antibiotic- mouldy bread on wounds o *Chinese: mouldy soybean curds for infection - After WWI, dawn of antibiotics- Julius Wagner-Jauregg o Syphillis parasite sensitive to heat- could be cured with high fever o Treatment: give people malaria- high fever- killed off syphillis o Malaria could be treated with quino (drug available at the time) o Turns into neurosyphillis and kills - Ironically, year after he got Nobel Prize (1927), Fleming (1928) discovered penicillin (antibiotics) so he could cure syphillis without giving malaria o First real antibiotic o Microorganisms produce these things- compete for a niche- different species of bacteria competing for same place- dump out substances that would kill the others o Selection for bacteria that produce these antibiotic substances o Was doing experiments- thought his nasal mucus had antibacterial effects- smeared a plate with staphylococcus aureus and pneumonia o 1928- smeared plate with staph., left, lab below was working on fungus called penicillium o Returned, his plates were messed up, then saw that clear halo around fungus that contaminated- fungal spore flew in and landed in dish- had chance to grow up before bacteria did, so it could produce antibiotic and bacteria could grow in circle around it o First to recognize importance of his findings- chance favours the prepared mind - Florey and Chain could scale up production of fungus (penicillin) o Got Nobel Prize along with Fleming o Could produce lots in time for WWII - Start of large-scale pharmaceutical production o Companies like to make lots of money making drugs that you use for the rest of your life, rather than antibiotics o Less appealing financially - Insulin is protein (not small-molecule drug)- but still one of big pharmaceutical discoveries o Treatment for diabetes used to be starving the person- but it would take longer to starve to death than just take the sugar o Hard to purify the insulin- pancreas produces digestive enzymes to go into intestines- when you try to purify insulin, gets broken down by enzymes - Banting and Best o Extracts of pancreas, in dogs o Purified insulin from pancreas o Controversial in their time- treating people for diabetes with something purified from dog pancreas o Public has trouble accepting these things o Governor (NY?) Hughes had daughter Elizabeth, with diabetes, tried to get them to test his daughter, she lived. Because that happened, she became famous patient and it was accepted. - Chemically synthesized from individual amino acids in 1963, by Linus Pauling - Boyer (recombinant DNA) - Swanson (business guy) o Excited by Boyer and Cohen’s discovery o Contacted Boyer o Genentech o Moving technology from lab bench to clinic - Pharmaceutical industry and biotechnology industry interactions o Biotech is good at finding things, but can’t go through clinical trials and bring it to markets o Need infrastructure (for testing, doctors, etc.) o Partnered with pharm. Industries (Lilly) to bring it to market - Hoffman- another pharm. Comp - Access to Excellence- lots of tutorials and info about biotech - Genomics: o Recombinant systems produced from microorganisms o Etc. - Modern biotech: genomics and proteomics important - A lot more drugs coming out now - Don’t need to memorize the top ten biotech proteins, but important to keep in mind - Epoetin alpha- synthesize red blood cells- helps with renal disease (kidney disease) - Over half of new biotech drugs targeted towards treating cancer - Lots of biotech companies have partnered with pharm. Companies because of the complexity and costs of clinical research - Also very stringing regulations in all countries- gov. policies - Pricing- money used to develop makes them expensive - High-risk investment- most drugs don’t make it to market- but it pays off when it’s in market - Phase I- safety- first time it’s tried in humans (does it kill a person?) - Phase II- define the dose o Difference in the way each person metabolizes drugs - Phase III- have to pay nurses, doctors, statisticians, etc. - Phase IV- can be used for more than one thing - Takes less time if it treats fatal disease (HIV) - Can be over $1 billion for a drug - Have to show that drug benefits individual o Lowers cholesterol- so what? o Do longer studies - Colon cancer- modern treatment (with recombinant drugs)- $250,000 - Politicians and other people should ask whether it’s worth the $20,000/extra month - This is all an industry- want to ensure future investments o Favourable cost-effective analysis- make sure the thing works o Drug costs still lass than 10% of total costs of healthcare- main thing is salaries o Should prices be based on cost of production? What is value of drug? Why are prices lower in other countries? Ask yourself. - Insurance companies- co-pays (you pay part and they pay part) - We don’t really have legislation on this stuff - U.S.- biggest place for patents in the world o Biggest pharm. Market o Patent agent gives you right to sue someone if they steal your invention o Copyright- physical manifestation of the idea - US patent, European Union Patent, Rest of World patent - Patent expires- generic drug makers take over- patent companies try to do patent extension to not lose all that money - Market risk- someone else will have come up with better idea • Movie with Harrison Ford and Brendan Fraser- Extraordinary Measures - brewery- vats for yeast- same thing as bioreactors - Milwaukee- became biotech centre o Breweries dying out in ‘70s and ‘80s, bought by biotech companies o Converted fermenters into something to grow industrial enzymes in - Things like EPO are more expensive to manufacture because you grow them in mammalian cells - One of biggest countries for vaccine production- Cuba o Lots of countries had been producing lots of vaccines before Soviet Russia collapsed o They picked up the slack- vaccines for developing world - We don’t have many antiviral drugs o Virus mutates so fast - Also don’t have many antifungal drugs - Vaccines treat virus infections before they happen - Vampire bat- blood clots and saliva pushes it back to unclotting o Lives on blood, evolved effective enzyme o Recombinant tPA or tPA - tPA: causes blood clot of damaged tissue to break up- plasminogen gets activated to plasmin, fibrin of clot breaks down, clot dissolves - *Urokinase inhibits, streptokinase activates it (this is the standard treatment) - Myloloma cell line=cancer cell line - Can harvest broth they’re growing in, purify it o CHO cells are used a lot in biotech o CHO cells make t-PA and dump it out into cell culture o These become transgenic cells (CHO) o Use recombinant DNA to make it- rtPA - First example of protein produced using pharming technique - Murine Whey Acid Protein Promotor- DNA tells gene to only express if it grows in milk - LA- long acting- protein’s been engineered to work better o Glycosylated- sugars added o Stays in blood longer - Zygote from goat- inject in vector DNA (designed to only express in goat’s milk) o Some in nucleus o A few incorporated into chromosome o Both daughter cells will get it- have altered germline o Only cells that produce milk can express the protein o Recombinant zygote implanted into goat- gives birth to baby goat- baby produces milk- tPA - Argument: this is natural product- FDA refuses at first - Should companies produce drugs that are marginally more effective and maximally less expensive? - US patent for tPA- suing-o-rama o Genentech sues Wellcome and another group for collaborating to create tPA, etc. o Lawyers make a lot of background, especially with science background - Is cost of making recombinant products the most useful use of resources- big issue - Genomics helps biotech identify drug targets o If you’re going to develop recombinant protein, must have target it mind o Find out what genes are involved o Find it in mice, remove gene from mouse (knock-out) o So much redundancy in mammals- still live o Helpful for learning about function of gene o We do inducible knock-outs- before, genome would be turned off throughout entire lifetime- now, gene functions fine, give it drug with gene turned off and see how it reacts - Need research to identify how patients respond to things- some people have really bad reaction to general anaesthetic, for instance o Some people with mutation in mitochondria have near fatal reaction to general anaesthetic o Tailor a treatment to individual based on genome: Phamacogenomics  To do that, need DNA profile - Pharmacogenomics o In order to tailor treatment to individual, need
More Less

Related notes for BIOL 1010

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit